Clinical Trials Browser

Terminated × Neoplastic Cells, Circulating × Clear all

Colonic Neoplasms, Neoplastic Cells, Circulating, Neoplasms

NCT05437679 2023-09-05

CHARTER

Terminated

9 enrolled

Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT04168931 2023-01-17

GASTHER2

Phase 2 Terminated

5 enrolled

Gastrointestinal

Neoplastic Cells, Circulating, Stomach Neoplasms

NCT01380795 2020-01-27

CTC-Poumon

Phase EARLY_PHASE1 Terminated

30 enrolled

Neoplastic Cells, Circulating

NCT03070002 2018-11-20

Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells

Phase 2 Terminated

1 enrolled 6 charts

Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT01286883 2018-08-20

Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells

Terminated

33 enrolled

Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT01884129 2015-12-10

CTCHNSCC01

Terminated

53 enrolled

Head & Neck

Carcinoma, Squamous Cell, Death, Head and Neck Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Recurrence

NCT01658332 2015-07-30

CIRCUBRONCH

Phase NA Terminated

59 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplastic Cells, Circulating

Clinical Trials

ARFIM

CHARTER

GASTHER2

CTC-Poumon

Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells

Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells

CTCHNSCC01

CIRCUBRONCH